Loading company…
Won 6 federal SBIR/STTR research awards from HHS and other federal agencies.
LEXEO Therapeutics LLC has been awarded 6 US Small Business Innovation Research (SBIR/STTR) contracts totalling $2,925,591 between 2018 and 2020. These are non-dilutive federal research grants, not equity financing. The company is based in New York, New York.
No investors recorded yet for LEXEO Therapeutics LLC.
Add an investorLEXEO Therapeutics LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for LEXEO Therapeutics LLC.
Add diversity data